Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Probiotix HealthFRA:X90 PS Ratio is 3.86 as of Jul. 16, 2026, which is 34% below its 10-year median of 5.89. The stock has 1 warning sign investors should review. Among 930 Biotechnology companies, Probiotix Health ranks better than 66.56% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Probiotix Health's share price is €0.0695.
Probiotix Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.02. Hence, Probiotix Health's PS Ratio for today is 3.86.
The historical rank and industry rank for Probiotix Health's PS Ratio or its related term are showing as below:
FRA:X90'
s PS Ratio Range Over the Past 10 Years
Min: 1.79 Med: 5.89 Max: 34.29
Current: 5
During the past 7 years, Probiotix Health's highest PS Ratio was 34.29. The lowest was 1.79. And the median was 5.89.
FRA:X90's PS Ratio is ranked better than 66.56% of 930
companies
in the Biotechnology industry
Industry Median: 9.655
vs FRA:X90: 5.00
During the past 7 years, Probiotix Health's highest 3-Year average Revenue per Share Growth Rate was 67.10% per year. The lowest was 26.00% per year. And the median was 46.55% per year.
Back to Basics: PS Ratio
Probiotix Health (FRA:X90) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Probiotix Health PS Ratio Related Terms
Probiotix Health PS Ratio Historical Data
* Premium members only.
The historical data trend for Probiotix Health's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Probiotix Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Probiotix Health PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Probiotix Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Probiotix Health's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Probiotix Health's Share Price of today is €0.0695.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Probiotix Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Probiotix Health (FRA:X90) has a PS Ratio of 3.86 as of Jul. 16, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Probiotix Health and its competitors. This is 34% below median its historical median of 5.89. Over the past decade, Probiotix Health's PS Ratio has ranged from 1.79 to 34.29. According to the industry distribution chart, Probiotix Health ranks #311 out of 930 companies in the Biotechnology industry, placing it in the top 33.4%.
Is Probiotix Health's PS Ratio too high?
Probiotix Health's current PS Ratio of 3.86 is 34% below median its 10-year median of 5.89. Over the past 10 years, this metric has ranged from a low of 1.79 to a high of 34.29. The Biotechnology industry median PS Ratio is 9.66. Probiotix Health's value of 3.86 is 60% below this industry median. Based on the distribution chart, Probiotix Health ranks #311 out of 930 companies in the Biotechnology industry, which is above the industry midpoint.
How does Probiotix Health's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Probiotix Health ranks #311 out of 930 companies for PS Ratio. This puts Probiotix Health in the upper half of its industry. The industry median PS Ratio is 9.66. Probiotix Health's value of 3.86 is 60% below this benchmark. Historically, Probiotix Health's own PS Ratio has ranged from 1.79 to 34.29 over the past decade. While the company's 10-year median is 5.89 vs. the industry median of 9.66, Probiotix Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.66, based on 930 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Probiotix Health's current PS Ratio of 3.86 is 60% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Probiotix Health and its competitors. For the Biotechnology industry, the median PS Ratio is 9.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Probiotix Health's current PS Ratio is 3.86, which is 34% below median its own 10-year median of 5.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Probiotix Health stock overvalued right now?
Probiotix Health (FRA:X90) has a current PS Ratio of 3.86. The stock's GF Value™ is €0.09, compared to a current price of €0.07 — trading 22.8% below its estimated fair value. The current PS Ratio is 3.86, which is 34% below median its 10-year median of 5.89 and 60% below the Biotechnology industry median of 9.66. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Probiotix Health (FRA:X90), the current PS Ratio is 3.86 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Probiotix Health PLC is a life sciences company that develops probiotics to tackle cardiovascular disease and other lifestyle conditions that are affecting growing numbers of people across the world. The company has one class of business, in three geographical areas, being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry. Its geographical segments include the United Kingdom, the United States, and the Rest of the World. It generates the majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:X90 has been successfully added to your 
